Kevin Ess is one of the organisers for 7th ATP1A3 symposium in Disease
In this interview he tells us about the stem cell lines that his laboratory in Vanderbilt is working on. Also he tells us the progress we have made in the last 10 years and what we are doing in the near future.
Dr. Ess graduated from the University of Cincinnati with a B.M. in Music Performance (1989).
He then earned a PhD in Developmental Biology (1996) and a M.D. degree (1998) from the University of Cincinnati.
After an internship in Pediatrics at Denver Children’s Hospital, then did a Child Neurology residency at Washington University, St. Louis Children’s Hospital.
Dr. Ess then completed fellowship training in Pediatric Neurophysiology at Washington University, St. Louis Children’s Hospital as well as post-doctoral research in Dr. David Gutmann’s laboratory.
He was an Instructor of Neurology and Pediatrics at Washington University in St. Louis from 2004-2006.
Dr. Ess joined the faculty at Vanderbilt University Medical Center in 2006 and is currently Associate Professor in the Departments of Pediatrics and Neurology.
He is the Division Director of Pediatric neurology and Neurologist-in-Chief of Monroe Carrell Children’s Hospital at Vanderbilt where he holds the Gerald M. Fenichel Chair in Neurology.
He is also a member of the Vanderbilt Kennedy Center for Research on Human Development.
His research interests are on mechanisms of normal cortical development and how genetic aberrations result in brain malformations, epilepsy, and autism.
His clinical activities focus on the management of intractable epilepsy in children.
This includes medical therapies as well as diet and surgical management.
He has a special interest in the diagnosis, treatment, and the basic science of the genetic disorders Tuberous Sclerosis Complex and Alternating Hemiplegia of Childhood.
